The RI investment comes on the back of three other recently completed transactions in Malaysia and Singapore in the last two months
With over 20 years of international leadership experience, Dr. Amrein has led many teams and organizations across over 30 geographies
AOI is the leading cancer hospital chain of South Asia operating 16 cancer hospitals in the region
Investment in technology and people and a meaningful industry-academia partnership can fuel the growth of the Indian biopharma sector
As the Covid-19 pandemic continues to have a disproportionate impact on women, Organon issues a call to action for other leaders to create opportunities to focus on women’s health
Expanding the Applied Biosystems portfolio with the latest generation of innovative, mid-throughput genetic analyzers
Meteoric Biopharmaceuticals have made rapid strides in the development of enzymes, probiotics and veterinary health products. It is seeking opportunities to scale up its growth backed by cutting edge R&D. Gaurav Kaushik, MD & CEO, Meteoric Biopharmaceuticals spoke to Thomas C Thottathil on the way forward
OmniActive seeks to improve lives by enhancing nutrition and wellness through science and innovation
Technology adoption helped the industry to sail through Covid-19 disruption as it understood the need to digitize, learn, and excel
N Yuvraj, Joint Secretary, Dept of Pharmaceuticals, Satish Reddy, Chairman, Dr Reddy’s Laboratories; Kiran Mazumdar Shaw, Executive Chairperson, Biocon Group; Sanjiv Navangul, MD & CEO, Bharat Serums and Vaccines and Shravil Patel, MD, Zydus Lifesciences discuss the way forward for the India pharma industry
Subscribe To Our Newsletter & Stay Updated
